June 18, 2020
Revealing 5 hidden truths about using a hub-and-spoke model for rare and orphan drugs
The hub-and-spoke approach has become a standard of drug commercialization. Having a network of patient…
Read More
June 16, 2020
Debunking 6 Myths About Gaining Payer Access for Rare and Orphan Drugs
What works for large patient populations isn’t necessarily a good fit for those with rare…
Read More
Rare Voices Podcast
- S1E3: Ken Greathouse, serial entrepreneur and philanthropist July 7, 2020
- S1E2: Jim Clement, Coues Consulting July 7, 2020
- S1E1: Candace Lerman, RareCandace.com July 7, 2020